A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis.
about
Memory and cognition in preclinical dementia: what we know and what we do not know.Free Recall Episodic Memory Performance Predicts Dementia Ten Years prior to Clinical Diagnosis: Findings from the Betula Longitudinal Study.Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.Onset and rate of cognitive change before dementia diagnosis: findings from two Swedish population-based longitudinal studies.APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's disease.Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment.
P2860
A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A preclinical phase in vascula ...... three years before diagnosis.
@en
A preclinical phase in vascula ...... three years before diagnosis.
@nl
type
label
A preclinical phase in vascula ...... three years before diagnosis.
@en
A preclinical phase in vascula ...... three years before diagnosis.
@nl
prefLabel
A preclinical phase in vascula ...... three years before diagnosis.
@en
A preclinical phase in vascula ...... three years before diagnosis.
@nl
P2093
P2860
P356
P1476
A preclinical phase in vascula ...... three years before diagnosis.
@en
P2093
Erika Jonsson Laukka
Lars Bäckman
Laura Fratiglioni
Sari Jones
P2860
P304
P356
10.1159/000080021
P50
P577
2004-07-29T00:00:00Z